InvestorsHub Logo
Followers 4
Posts 77
Boards Moderated 0
Alias Born 01/31/2015

Re: RiverNorth post# 1109

Thursday, 03/26/2015 12:44:53 PM

Thursday, March 26, 2015 12:44:53 PM

Post# of 3683
Considering the size of the I.S. market, if the Ph2 news is excellent, it is easy to imagine the stock being revalued to around $1 Billion market cap.

Seems reasonable with the market being in excess of $15 Billion.

I would love to see results that are superior to rtPa phase 3 results.

Considering the time advantage (ATHX's trial is administering Multistem 24-36 hrs post stroke) if Multistem shows the same or greater benefit vis a vis rtPa, then we have a winner here.